ADMA Biologics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

7. SEGMENTS (Details)

7. SEGMENTS (Details) (USD $)	3 Months Ended
7. SEGMENTS (Details) (USD $)	Mar. 31, 2015	Mar. 31, 2014
Summarized financial information concerning reportable segments
Revenues	$ 1,503,106us-gaap_Revenues	$ 1,560,559us-gaap_Revenues
Cost of product revenue	909,629us-gaap_CostOfGoodsSold	977,030us-gaap_CostOfGoodsSold
Gross profit	593,477us-gaap_GrossProfit	583,529us-gaap_GrossProfit
Loss from operations	(3,202,337)us-gaap_OperatingIncomeLoss	(5,683,986)us-gaap_OperatingIncomeLoss
Other income (expense)	(403,198)us-gaap_NonoperatingIncomeExpense	(219,886)us-gaap_NonoperatingIncomeExpense
Net loss	(3,605,535)	(5,903,872)
Property and equipment, net	2,737,762ADMA_PropertyPlantAndEquipmentNet1	828,948ADMA_PropertyPlantAndEquipmentNet1
Depreciation and amortization expense	117,122us-gaap_DepreciationAndAmortization	48,299us-gaap_DepreciationAndAmortization
Plasma Collection Center Member
Summarized financial information concerning reportable segments
Revenues	1,484,217	1,541,670
Cost of product revenue	909,629	977,030
Gross profit	574,588	564,640
Loss from operations	(473,506)	(237,829)
Other income (expense)	0	(1,730)
Net loss	(473,506)	(239,559)
Property and equipment, net	2,592,473	655,342
Depreciation and amortization expense	104,917	35,983
Research And Development Member
Summarized financial information concerning reportable segments
Revenues	0	0
Cost of product revenue	0	0
Gross profit	0	0
Loss from operations	(1,401,723)	(4,330,457)
Other income (expense)	0	0
Net loss	(1,401,723)	(4,330,457)
Property and equipment, net	0	1,920
Depreciation and amortization expense	0	809
Corporate Member
Summarized financial information concerning reportable segments
Revenues	18,889	18,889
Cost of product revenue	0	0
Gross profit	18,889	18,889
Loss from operations	(1,327,108)	(1,115,700)
Other income (expense)	(403,198)	(218,156)
Net loss	(1,730,306)	(1,333,856)
Property and equipment, net	145,289	171,686
Depreciation and amortization expense	$ 12,205	$ 11,507